Recently, the cough and cold medicine market waves again. Anhui Sihuan Kebao Pharmaceutical's Ambroxol Hydrochloride Oral Solution, Hainan Allstar Pharmaceutical's Ambroxol Oral Solution and five other products were approved on the same day, and 12 product sizes have been approved for marketing so far this year. MiNe data show that the cough and cold medicine in 2024 Q1-Q3 China retail pharmacy terminal sales growth of nearly 15%. top 20 reshuffle, “king of the drug” to change the owner, huarun sanjiu, koi flower on the list. 2 improved new drugs hot coming, kangzhi pharmaceutical, Beijing fuyuan pharmaceutical, hefei national medicine and pharmaceutical and so on! The impact of the first generic.